Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Nov 15, 2024; 16(11): 4409-4423
Published online Nov 15, 2024. doi: 10.4251/wjgo.v16.i11.4409
Published online Nov 15, 2024. doi: 10.4251/wjgo.v16.i11.4409
Table 3 Treatments and outcomes of patients in the No-gastrointestinal complications vs gastrointestinal complications groups of aggressive primary gastrointestinal non-Hodgkin lymphomas
| Characteristics | No-GICs (n = 64) | GICs (n = 60) | P value |
| Chemotherapy, n (%) | 0.000 | ||
| No | 3 (4.7) | 17 (28.3) | |
| Yes | 61 (95.3) | 43 (71.7) | |
| Radiotherapy, n (%) | 0.022 | ||
| No | 49 (76.6) | 55 (91.7) | |
| Yes | 15 (23.4) | 5 (8.3) | |
| Surgery, n (%) | 0.000 | ||
| No | 61 (95.3) | 5 (11.7) | |
| Yes | 3 (4.7) | 53 (88.3) | |
| Treatment, n (%) | |||
| Without CT | 3 (4.7) | 17 (28.3) | 0.000 |
| CT alone | 43 (67.2) | 4 (6.7) | |
| CT + Sur/RT | 18 (28.1) | 39 (65.0) | |
| EFS time, M (IQR) | 21.0 (11.0, 36.0) | 17.0 (5.5, 36.0) | 0.580 |
| OS time, M (IQR) | 28.5 (14.5, 45.0) | 24.5 (6.5, 47.5) | 0.335 |
| Death toll, n (%) | 20 (31.3) | 26 (43.3) | 0.164 |
- Citation: Liu XH, Chen G, Cao DD, Liu H, Ke XK, Hu YG, Tan W, Ke D, Xu XM. Comparison of clinical features of patients with or without severe gastrointestinal complications in aggressive gastrointestinal lymphomas. World J Gastrointest Oncol 2024; 16(11): 4409-4423
- URL: https://www.wjgnet.com/1948-5204/full/v16/i11/4409.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i11.4409